Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-Term vs 6-Week Prednisone in Subacute Thyroiditis
NCT06285617Phase 3Not yet recruiting
- Sponsor
- Xinqiao Hospital
- Start
- Apr 2024
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of celecoxib in subacute thyroiditis (SAT), sponsored by Xinqiao Hospital. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
celecoxib
03
Conditions
subacute thyroiditis (SAT)
Beyond the preview
Go deeper on NCT06285617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06285617.